Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-015811 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +14.0K | 39.6K | +55% | $0 |
| D | 2022-03-03 | 2022-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $66.62 | -2,886 | 25.5K | -10% | -$192.3K |
| D | 2022-03-03 | 2022-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +24.9K | 24.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | A | A | 14,000 | $0.00 | 39,578 | D | — | — | (F3) Includes 106 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021. (F4) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |
| 2 | Common | Common Stock | 2022-03-01 | S | D | 2,886 | $66.62 | 25,472 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.62 to $66.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | A | A | 24,900 | $0.00 | 24,900 | D | $67.37 · — to 2032-03-01 | 24,900 Common Stock | (F5) On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date. |